[1] Pozo Laderas JC,Pontes Moreno A,Pozo Salido C,et al.Disseminated mucormycosis in immunocompetent patients:a disease that also exists[J].Rev Iberoam Micol,2015,32(2):63-70.
[2] 杨士芳,吴健.老年男性肺毛霉菌病1例[J].中华老年多器官疾病杂志,2011,10(6):548-552. [3] Long B,Koyfman A.Mucormycosis:what emergency physicians need to know[J].Am J Emerg Med,2015,33(12):1823-1825.
[4] Danion F,Aguilar C,Catherinot E,et al.Mucormycosis:new developments into a persistently devastating infection[J].Semin Respir Crit Care Med,2015,36(5):692-705.
[5] McAdams HP,Rosado de Christenson M,Strollo DC,et al.Pulmonary mucormycosis:radiologic findings in 32 cases[J].AJR Am J Roentgenol,1997,168(6):1541-1548.
[6] Jung J,Kim MY,Lee HJ,et al.Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis[J].Clin Microbiol Infect,2015,21(7):684-611.
[7] Chitasombat MN,Kontoyiannis DP.Treatment of mucormycosis in transplant patients:role of surgery and of old and new antifungal agents[J].Curr Opin Infect Dis,2016,29(4):340-345.
[8] Ville S,Talarmin JP,Gaultier-Lintia A,et al.Disseminated mucormycosis with cerebral involvement owing to Rhizopus microsporus in a kidney recipient treated with combined liposomal amphotericin B and posaconazole therapy[J].Exp Clin Transplant,2016,14(1):96-99.
[9] Graves B,Morrissey CO,Wei A,et al.Isavuconazole as salvage therapy for mucormycosis[J].Med Mycol Case Rep,2016,11:36-39.
[10] Miceli MH,Kauffman CA.Isavuconazole:a new broad-spectrum triazole antifungal agent[J].Clin Infect Dis,2015,61(10):1558-1565.